循环miRNA作为腹主动脉瘤诊断、监测及术后随访的生物标志物
本文综述了2012至2022年MEDLINE收录的25篇关于循环miRNA作为腹主动脉瘤(AAA)生物标志物的研究,共纳入1,259例AAA患者(男性1,040例,90%)。其中9种miRNA(miR-145、miR-24、miR-33、miR-125、let-7、miR-15、miR-191、miR-29、miR-133)在超过2篇文献中被研究,并参与AAA已知的发病机制。作者认为识别疾病特异性miRNA并结合其他临床参数对AAA早期诊断和随访至关重要,未来研究需严格的病例对照定义、样本采集方案和miRNA表达谱技术。
要点
- 9种miRNA在超过2篇文献中被研究,参与AAA的动脉粥样硬化、血管炎症等机制。
- 多数研究采用血浆样本,最常用的miRNA检测方法为qRT-PCR。
- 作者认为识别疾病特异性miRNA并结合临床参数对AAA早期诊断和随访至关重要。
核心结论
- 本综述所述的9种miRNA参与AAA已知的发病机制,如动脉粥样硬化、血管平滑肌细胞表型转换与凋亡、血管炎症、细胞外基质降解和脂质代谢。
- 作者认为识别疾病特异性miRNA并结合其他临床参数作为AAA的指标,对AAA的早期诊断和随访至关重要。
- 作者提出未来关于miRNA作为AAA生物标志物的研究需要严格的病例组和对照组定义、样本采集方案以及miRNA表达谱技术。
研究设计与样本
- 本文为文献综述,检索MEDLINE数据库,仅纳入涉及外周血样本(全血、血浆和血清)的报告。
- 检索词组合包括microrna、mirna、AAA、human、circulating、plasma、serum、endovascular和endovascular aneurysm repair(EVAR)。
- 共纳入25篇报告,发表于2012年至2022年,合计1,259例AAA患者,以男性为主(N=1,040,90%)。
- 其中6篇报告招募了接受超声筛查AAA的健康供者作为对照样本。
主要发现
- 共纳入25篇报告,发表于2012年至2022年,合计1,259例AAA患者,以男性为主(N=1,040,90%)。
- 6篇报告招募了接受超声筛查AAA的健康供者作为对照样本。
- 多数研究采用血浆样本,最常用的miRNA谱分析方法为实时定量聚合酶链反应(qRT-PCR)。
- 在总计76种miRNA中,以下9种在超过2篇文献中被研究:miR-145、miR-24、miR-33、miR-125、let-7、miR-15、miR-191、miR-29和miR-133。
关键数值与推荐
- 共纳入25篇报告,发表于2012年至2022年,合计1,259例AAA患者,以男性为主(N=1,040,90%)。
- 6篇报告招募了接受超声筛查AAA的健康供者作为对照样本。
- 在总计76种miRNA中,以下9种在超过2篇文献中被研究:miR-145、miR-24、miR-33、miR-125、let-7、miR-15、miR-191、miR-29和miR-133。
- 多数研究采用血浆样本,最常用的miRNA谱分析方法为实时定量聚合酶链反应(qRT-PCR)。
临床怎么用
- 作者认为识别疾病特异性miRNA并结合其他临床参数作为AAA的指标,对AAA的早期诊断和随访至关重要。
- 作者提出未来关于miRNA作为AAA生物标志物的研究需要严格的病例组和对照组定义、样本采集方案以及miRNA表达谱技术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To provide a summary of the current state of research in English medical literature on circulating miRNAs as biomarkers for abdominal aortic aneurysm (AAA). Additionally, for the most commonly mentioned circulating miRNAs in the literature, to attempt a documentation of the biological mechanisms underlying their role in AAA development. METHODS: A literature search was undertaken in the MEDLINE database. Only reports that involved peripheral blood samples (whole blood, plasma, and serum) were included. The following terms were used in combination: microrna, mirna, AAA, human, circulating, plasma, serum, endovascular, and endovascular aneurysm repair (EVAR). RESULTS: A total of 25 reports, published from 2012 to 2022 were included with a total of 1,259 patients with AAA, predominantly men (N = 1,040, 90%). Six of these reports recruited healthy donors who underwent ultrasound screening for AAA as control samples. The majority of studies were undertaken in plasma samples and the most preferred microRNA profiling method was real - time quantitative polymerase chain reaction (qRT-PCR). The following 9 miRNAs (out of a total of 76) were studied in more than 2 references: miR-145, miR-24, miR-33, miR-125, let-7, miR-15, miR-191, miR-29, and miR-133. CONCLUSIONS: The 9 miRNAs described in this study, are implicated in known pathogenetic mechanisms of AAA, such as atherosclerosis, vascular smooth muscle cell (VSMCs) phenotype switch and apoptosis, vascular inflammation, extracellular matrix (ECM) degradation, and lipid metabolism. Identifying disease-specific miRNAs, in combination with other clinical parameters, as indicators of AAA, is crucial for early diagnosis as well as follow-up of AAAs. For future research on miRNAs as AAA biomarkers, strict case and control group definitions, sample acquisition protocols, and miRNA expression profiling techniques are warranted.
引用
- Tasopoulou KM, Argiriou C, Tsaroucha AK, et al. Circulating miRNAs as Biomarkers for Diagnosis, Surveillance, and Postoperative Follow-Up of Abdominal Aortic Aneurysms. Ann Vasc Surg. 2023. PMID: 36921794. doi:10.1016/j.avsg.2023.02.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。